BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 17577578)

  • 1. F2L, a peptide derived from heme-binding protein, inhibits formyl peptide receptor-mediated signaling.
    Lee HY; Lee SY; Shin EH; Kim SD; Kim JM; Lee MS; Ryu SH; Bae YS
    Biochem Biophys Res Commun; 2007 Aug; 359(4):985-90. PubMed ID: 17577578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
    Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C
    Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR.
    Prat C; Haas PJ; Bestebroer J; de Haas CJ; van Strijp JA; van Kessel KP
    J Immunol; 2009 Nov; 183(10):6569-78. PubMed ID: 19846866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils.
    Bae YS; Park JC; He R; Ye RD; Kwak JY; Suh PG; Ho Ryu S
    Mol Pharmacol; 2003 Sep; 64(3):721-30. PubMed ID: 12920210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trp-Arg-Trp-Trp-Trp-Trp antagonizes formyl peptide receptor like 2-mediated signaling.
    Shin EH; Lee HY; Kim SD; Jo SH; Kim MK; Park KS; Lee H; Bae YS
    Biochem Biophys Res Commun; 2006 Mar; 341(4):1317-22. PubMed ID: 16476585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation.
    Le Y; Gong W; Li B; Dunlop NM; Shen W; Su SB; Ye RD; Wang JM
    J Immunol; 1999 Dec; 163(12):6777-84. PubMed ID: 10586077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Trp-Nle-Tyr-Met as a novel agonist for human formyl peptide receptor-like 1.
    Wan HX; Zhou C; Zhang Y; Sun M; Wang X; Yu H; Yang X; Ye RD; Shen JK; Wang MW
    Biochem Pharmacol; 2007 Jul; 74(2):317-26. PubMed ID: 17517377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling.
    Bae YS; Lee HY; Jo EJ; Kim JI; Kang HK; Ye RD; Kwak JY; Ryu SH
    J Immunol; 2004 Jul; 173(1):607-14. PubMed ID: 15210823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the ratio between FPR and FPRL1 triggered superoxide production in human neutrophils-a tool in analysing receptor specific events.
    Fu H; Karlsson J; Björkman L; Stenfeldt AL; Karlsson A; Bylund J; Dahlgren C
    J Immunol Methods; 2008 Feb; 331(1-2):50-8. PubMed ID: 18166194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional expression of formyl peptide receptor family in human NK cells.
    Kim SD; Kim JM; Jo SH; Lee HY; Lee SY; Shim JW; Seo SK; Yun J; Bae YS
    J Immunol; 2009 Nov; 183(9):5511-7. PubMed ID: 19843937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of an endogenous chemotactic ligand specific for FPRL2.
    Migeotte I; Riboldi E; Franssen JD; Grégoire F; Loison C; Wittamer V; Detheux M; Robberecht P; Costagliola S; Vassart G; Sozzani S; Parmentier M; Communi D
    J Exp Med; 2005 Jan; 201(1):83-93. PubMed ID: 15623572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The peptide Trp-Lys-Tyr-Met-Val-D-Met activates neutrophils through the formyl peptide receptor only when signaling through the formylpeptide receptor like 1 is blocked. A receptor switch with implications for signal transduction studies with inhibitors and receptor antagonists.
    Karlsson J; Fu H; Boulay F; Bylund J; Dahlgren C
    Biochem Pharmacol; 2006 May; 71(10):1488-96. PubMed ID: 16549058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F2L, a peptide derived from heme-binding protein, chemoattracts mouse neutrophils by specifically activating Fpr2, the low-affinity N-formylpeptide receptor.
    Gao JL; Guillabert A; Hu J; Le Y; Urizar E; Seligman E; Fang KJ; Yuan X; Imbault V; Communi D; Wang JM; Parmentier M; Murphy PM; Migeotte I
    J Immunol; 2007 Feb; 178(3):1450-6. PubMed ID: 17237393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8.
    Fu H; Bylund J; Karlsson A; Pellmé S; Dahlgren C
    Immunology; 2004 Jun; 112(2):201-10. PubMed ID: 15147563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR.
    Rabiet MJ; Huet E; Boulay F
    Eur J Immunol; 2005 Aug; 35(8):2486-95. PubMed ID: 16025565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-infective peptide, innate defense-regulator peptide, stimulates neutrophil chemotaxis via a formyl peptide receptor.
    Lee HY; Bae YS
    Biochem Biophys Res Commun; 2008 May; 369(2):573-8. PubMed ID: 18294454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential activation of formyl peptide receptor signaling by peptide ligands.
    Bae YS; Song JY; Kim Y; He R; Ye RD; Kwak JY; Suh PG; Ryu SH
    Mol Pharmacol; 2003 Oct; 64(4):841-7. PubMed ID: 14500740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1.
    Hu JY; Le Y; Gong W; Dunlop NM; Gao JL; Murphy PM; Wang JM
    J Leukoc Biol; 2001 Jul; 70(1):155-61. PubMed ID: 11435499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Processing of HEBP1 by cathepsin D gives rise to F2L, the agonist of formyl peptide receptor 3.
    Devosse T; Dutoit R; Migeotte I; De Nadai P; Imbault V; Communi D; Salmon I; Parmentier M
    J Immunol; 2011 Aug; 187(3):1475-85. PubMed ID: 21709160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2.
    Christophe T; Karlsson A; Dugave C; Rabiet MJ; Boulay F; Dahlgren C
    J Biol Chem; 2001 Jun; 276(24):21585-93. PubMed ID: 11285256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.